ArticleEvidence-based complementary and alternative medicine : eCAM2018
Inhibition of
Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 53 citations in OpenAlex.
- Chemical analysis, antihyperglycemic properties and enzyme inhibition ofJournal of pharmaceutical analysis · 2025Article
- The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated Complications.Current diabetes reviews · 2025Review
- Ethnopharmacological Study ofPlants (Basel, Switzerland) · 2024Article
- Exploring the therapeutic potential ofToxicology research · 2024Article
- Assessing seromuscular layer and serosa removal on intestinal permeability measurements in weaned piglet everted sac segments.Journal of animal science · 2024Article
- The Anti-Diabetic Effects of Medicinal Plants Belonging to the Liliaceae Family: Potential Alpha Glucosidase Inhibitors.Drug design, development and therapy · 2024Review
- Article
- Phytochemical Analysis, α-Glucosidase and α-Amylase Inhibitory Activities and Acute Toxicity Studies of Extracts from PomegranateFoods (Basel, Switzerland) · 2022Article
- PlantFrontiers in endocrinology · 2022Review
- Inhibition ofEvidence-based complementary and alternative medicine : eCAM · 2022Article
- In Vitro Antioxidant Properties, Glucose-Diffusion Effects, α-Amylase Inhibitory Activity, and Antidiabetogenic Effects ofAntioxidants (Basel, Switzerland) · 2021Article
- Linking the Phytochemicals and the α-Glucosidase and α-Amylase Enzyme Inhibitory Effects ofFoods (Basel, Switzerland) · 2021Article
- Bioactive Sugarcane Lipids in a Circular Economy Context.Foods (Basel, Switzerland) · 2021Review
- Article
- Evaluation of Hepatoprotective Activity ofAdvances in pharmacological and pharmaceutical sciences · 2021Article
- Comprehensive Chemical Profiling and Multidirectional Biological Investigation of Two WildMolecules (Basel, Switzerland) · 2019Article
- IntegratedDrug target insightsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many medicinal plants around the world are used for therapeutic purposes against several diseases, including diabetes mellitus. Due to their composition of natural substances that are effective and do not represent side effects for users, unlike synthetic drugs, in this study, we investigated the inhibitory effect of
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.